Published in Cell Cycle on September 19, 2006
miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell (2008) 2.57
MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Am J Physiol Heart Circ Physiol (2011) 1.59
Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. PLoS Pathog (2009) 1.53
The proto-oncogene LRF is under post-transcriptional control of MiR-20a: implications for senescence. PLoS One (2008) 1.37
Micromanaging vascular biology: tiny microRNAs play big band. J Vasc Res (2009) 1.31
Airway smooth muscle hyperproliferation is regulated by microRNA-221 in severe asthma. Am J Respir Cell Mol Biol (2014) 1.16
Implication of the miR-184 and miR-204 competitive RNA network in control of mouse secondary cataract. Mol Med (2012) 0.91
microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts. Cardiovasc Diagn Ther (2015) 0.89
A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell (2011) 10.50
Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell (2011) 7.02
MicroRNAs modulate the angiogenic properties of HUVECs. Blood (2006) 4.31
Connective tissue growth factor: a crucial cytokine-mediating cardiac fibrosis in ongoing enterovirus myocarditis. J Mol Med (Berl) (2007) 1.83
microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J (2011) 1.66
DjPum, a homologue of Drosophila Pumilio, is essential to planarian stem cell maintenance. Development (2005) 1.46
LRF is an essential downstream target of GATA1 in erythroid development and regulates BIM-dependent apoptosis. Dev Cell (2009) 1.39
The proto-oncogene LRF is under post-transcriptional control of MiR-20a: implications for senescence. PLoS One (2008) 1.37
MicroRNAs couple cell fate and developmental timing in retina. Proc Natl Acad Sci U S A (2009) 1.35
Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression. Cancer Res (2011) 1.06
Adult stem cell plasticity: neoblast repopulation in non-lethally irradiated planarians. Dev Biol (2009) 1.04
Ozone and cardiovascular injury. Cardiovasc Ultrasound (2009) 1.02
Deletion of PTENP1 pseudogene in human melanoma. J Invest Dermatol (2011) 1.00
MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis. J Biol Chem (2010) 0.96
The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanoma. PLoS One (2011) 0.94
miR-20a and miR-290, multi-faceted players with a role in tumourigenesis and senescence. J Cell Mol Med (2010) 0.93
An RbAp48-like gene regulates adult stem cells in planarians. J Cell Sci (2010) 0.90
Potentiation of gene targeting in human cells by expression of Saccharomyces cerevisiae Rad52. Nucleic Acids Res (2005) 0.89
The energy profiling of short interfering RNAs is highly predictive of their activity. Oligonucleotides (2004) 0.89
miR-290 acts as a physiological effector of senescence in mouse embryo fibroblasts. Physiol Genomics (2009) 0.89
Long non-coding RNAs in cancer: implications for personalized therapy. Cell Oncol (Dordr) (2014) 0.88
Nuclear sphingomyelin pathway in serum deprivation-induced apoptosis of embryonic hippocampal cells. J Cell Physiol (2006) 0.88
MicroRNAs mediate metabolic stresses and angiogenesis. Cell Mol Life Sci (2011) 0.88
DeltaN133p53 expression levels in relation to haplotypes of the TP53 internal promoter region. Hum Mutat (2010) 0.88
Fludarabine treatment favors the retention of miR-485-3p by prostate cancer cells: implications for survival. Mol Cancer (2013) 0.87
TSPO over-expression increases motility, transmigration and proliferation properties of C6 rat glioma cells. Biochim Biophys Acta (2007) 0.87
MiR-492 impairs the angiogenic potential of endothelial cells. J Cell Mol Med (2013) 0.86
A knowledge base for the discovery of function, diagnostic potential and drug effects on cellular and extracellular miRNAs. BMC Genomics (2014) 0.84
Immortalization of MEF is characterized by the deregulation of specific miRNAs with potential tumor suppressor activity. Aging (Albany NY) (2011) 0.84
PK 11195 differentially affects cell survival in human wild-type and 18 kDa translocator protein-silenced ADF astrocytoma cells. J Cell Biochem (2008) 0.83
Enhancement of gene targeting in human cells by intranuclear permeation of the Saccharomyces cerevisiae Rad52 protein. Nucleic Acids Res (2010) 0.82
The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation. Nucleic Acid Ther (2012) 0.82
Role of E2F1-cyclin E1-cyclin E2 circuit in human coronary smooth muscle cell proliferation and therapeutic potential of its downregulation by siRNAs. Mol Med (2009) 0.81
Hedgehog pathway blockade inhibits melanoma cell growth in vitro and in vivo. Pharmaceuticals (Basel) (2013) 0.80
Bcl2-low-expressing MCF7 cells undergo necrosis rather than apoptosis upon staurosporine treatment. Biochem J (2004) 0.80
A method for prediction of accessible sites on an mRNA sequence for target selection of hammerhead ribozymes. J Comput Biol (2002) 0.79
The silencing of adenine nucleotide translocase isoform 1 induces oxidative stress and programmed cell death in ADF human glioblastoma cells. FEBS J (2010) 0.79
A proteomic approach to the investigation of early events involved in vascular smooth muscle cell activation. Cell Tissue Res (2007) 0.79
A yeast-based genetic screening to identify human proteins that increase homologous recombination. FEMS Yeast Res (2008) 0.79
Resting smooth muscle cells as a model for studying vascular cell activation. Tissue Cell (2006) 0.79
The RNA activator ds-p21 potentiates the cytotoxicity induced by fludarabine in Dohh2 cells. Oligonucleotides (2011) 0.77
A proteomic approach to the investigation of early events involved in the activation of vascular smooth muscle cells. Cell Tissue Res (2007) 0.77
Preface. Pseudogenes. Methods Mol Biol (2014) 0.77
Immortalized mouse embryo fibroblasts are resistant to miR-290-induced senescence regardless of p53 status. Physiol Genomics (2011) 0.76
The Fuzzy Logic of MicroRNA Regulation: A Key to Control Cell Complexity. Curr Genomics (2010) 0.76
Effect of the administration of n-3 polyunsaturated fatty acids on circulating levels of microparticles in patients with a previous myocardial infarction. Haematologica (2008) 0.76
Bcl2-negative MCF7 cells overexpress p53: implications for the cell cycle and sensitivity to cytotoxic drugs. Cancer Chemother Pharmacol (2002) 0.76
Parallel decrease of tissue factor surface exposure and increase of tissue factor microparticle release by the n-3 fatty acid docosahexaenoate in endothelial cells. Thromb Haemost (2007) 0.76
Identification of active siRNAs against IGF-IR of porcine coronary smooth muscle cells in a heterologous cell line. Int J Mol Med (2005) 0.75
Targeting of A701G nucleotide at the human ATP1A1 locus using a RNA/DNA chimera. Nucleosides Nucleotides Nucleic Acids (2003) 0.75
Erratum to: Long non-coding RNAs in cancer: implications for personalized therapy. Cell Oncol (Dordr) (2015) 0.75
The sensitivity of MCF10A breast epithelial cells to alkylating drugs is enhanced by the inhibition of O6-methylguanine-DNA methyltransferase transcription with a synthetic double strand DNA oligonucleotide. Breast Cancer Res Treat (2002) 0.75